With Antiviral drugs, Time is of the essence. You have
a window of the first 24-36 hours. Ex. Tamiflu.
Before the viral load gets too high in the body. The real
need is that every state has to have the ability to test people at
every clinic, office, etc.. If you have to send out a test and it
takes 3 days to get back results, you have missed that window of
opportunity to treat with an antiviral (at least giving the best
odds of working). You have to weigh out the risk/reward ratio
with any drug. If the drug causes liver toxicity (is it acute
or chronic). Ex. If you drink heavily one night
(alcohol) then you will have acute liver toxicity. That
doesn't mean your live will go on to fail. Your liver is one
of the few organs that cells can reproduce/repair new cells.
So, if you have a person that is high risk and could die from
the Coronavirus, I would say that the reward is higher than risk to
take the antiviral. There is no "one size fits all" when
treating complex cases/co-morbidity. And 12 patients does not
make for a great study, your "P" values will not be too good.
Just the same as bascktesting, the more data you have
the better you can test your system. Now, we are in new
territory with this novel virus, so sometimes you have work with
what you have at the moment until proven otherwise. The
private sector is the only one that will bring about different
solutions to fight this virus, not the government ( recent test kit
debacle).
Newsletter
Subscribe to our email list for regular free market updates
as well as a chance to get coupons!
News about GILD testing results
Posted by golfmyway5 on 14th of Mar 2020 at 10:55 pm
News about GILD testing results
https://www.fool.com/investing/2020/03/14/early-results-dampen-outlook-for-experimental-covi.aspx
Much prefer properly sourced stem
Posted by steve on 15th of Mar 2020 at 01:44 pm
Much prefer properly sourced stem cells as a valid therapeutic
Covid Treatment
Posted by steve on 15th of Mar 2020 at 01:54 pm
https://www.wfaa.com/article/news/health/coronavirus/new-covid-19-treatment-has-helped-dozens-in-china-unthsc-researchers-say/287-22675c63-0cac-4837-843f-c7a0748afdc5
With Antiviral drugs, Time is
Posted by ssaffer on 15th of Mar 2020 at 01:25 am
With Antiviral drugs, Time is of the essence. You have a window of the first 24-36 hours. Ex. Tamiflu. Before the viral load gets too high in the body. The real need is that every state has to have the ability to test people at every clinic, office, etc.. If you have to send out a test and it takes 3 days to get back results, you have missed that window of opportunity to treat with an antiviral (at least giving the best odds of working). You have to weigh out the risk/reward ratio with any drug. If the drug causes liver toxicity (is it acute or chronic). Ex. If you drink heavily one night (alcohol) then you will have acute liver toxicity. That doesn't mean your live will go on to fail. Your liver is one of the few organs that cells can reproduce/repair new cells. So, if you have a person that is high risk and could die from the Coronavirus, I would say that the reward is higher than risk to take the antiviral. There is no "one size fits all" when treating complex cases/co-morbidity. And 12 patients does not make for a great study, your "P" values will not be too good. Just the same as bascktesting, the more data you have the better you can test your system. Now, we are in new territory with this novel virus, so sometimes you have work with what you have at the moment until proven otherwise. The private sector is the only one that will bring about different solutions to fight this virus, not the government ( recent test kit debacle).